Expression of 5LOXmRNA and VEGFmRNA in pancreatic cancer and its clinical significance
Author:
Affiliation:

Clc Number:

R735.9; Q58

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective;To investigate the expression of 5LOX in pancreatic cancer tissue and the relationship between 5LOX expression and expression of VEGF.Methods;The expression of 5LOXmRNA, VEGFmRNAin 35 pancreatic cancer fresh tissue samples were detected by semiquantitive reverse transcriptasepolymerase chain reaction method.Results;Expression of 5LOXmRNA,VEGFmRNA in pancreaticcancer tissue were 74.3%, 60% respectively,and the expression was correlated to the with clinicalstages of the tumor; also expression of VEGFmRNA was correlated to the differentiation of the tumor. Expression of 5LOXmRNA and VEGFmRNA were synergetic in pancreatic cancer(P<0.05), and were closely correlated(P<0.01). III~IV stages of pancreatic cancer showed significantly stronger expressions of 5LOX compared to in I~II stages of pancreatic cancer(P<0.05). Conclusions;Expression of 5LOX,VEGF in pancreatic cancer tissue was markedly elevated,and correlated to the clinical stages of the tumor; expression of 5LOX and VEGF were positively related in pancreatic cancer.

    Reference
    Related
    Cited by
Get Citation

LU Lihong, ZHANG Bo, ZENG Qingdong, SHAO Jun, YIN Jincen.Expression of 5LOXmRNA and VEGFmRNA in pancreatic cancer and its clinical significance[J]. Chin J Gen Surg,2005,14(11):4-816.
DOI:10.7659/j. issn.1005-6947.2005.11.004

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 01,1900
  • Revised:January 01,1900
  • Adopted:
  • Online: November 25,2005
  • Published: